Vimarsana
Biggest News Aggregation in the World

Page 41 - Pharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Inc Today - Breaking & Trending Today

Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.com - Vimarsana News

Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a report issued on Monday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Stock Down 2.9 % NASDAQ:EVOK opened at $1.32 on Monday. The company has a debt-to-equity ratio of 9.29, a current ratio of 3.50 […]

Source: wkrb13.com
Critical Analysis: Denali Therapeutics (NASDAQ:DNLI) & Innate Pharma (OTCMKTS:IPHYF) - Vimarsana News

Critical Analysis: Denali Therapeutics (NASDAQ:DNLI) & Innate Pharma (OTCMKTS:IPHYF)

Denali Therapeutics (NASDAQ:DNLI – Get Free Report) and Innate Pharma (OTCMKTS:IPHYF – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings and risk. Institutional and Insider Ownership 78.0% of Denali Therapeutics […]

MEI Pharma (NASDAQ:MEIP) Earns Hold Rating from Analysts at StockNews.com - Vimarsana News

MEI Pharma (NASDAQ:MEIP) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a research report report published on Sunday morning. The brokerage issued a hold rating on the stock. A number of other analysts have also recently issued reports on MEIP. Stifel Nicolaus lowered their target price on MEI Pharma from $10.00 to $9.00 […]

MEI Pharma (NASDAQ:MEIP) Coverage Initiated at StockNews.com - Vimarsana News

MEI Pharma (NASDAQ:MEIP) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a research report report published on Sunday. The brokerage issued a hold rating on the stock. Several other research analysts also recently weighed in on MEIP. Stifel Nicolaus lowered their price objective on shares of MEI Pharma from $10.00 to $9.00 and […]

Food And Drug Administration Grants Two New Label Changes To Tirosint®-Sol (Levothyroxine Sodium) Or - Vimarsana News

Food And Drug Administration Grants Two New Label Changes To Tirosint®-Sol (Levothyroxine Sodium) Or

New FDA-approved label updates offer patients more flexible administrationPARSIPPANY, N.J.--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) has approved two new changes to the label of Tirosint-SOL (levothyroxine sodium) oral solution, a unique formulation of levothyroxine (LT4) for the treatment of hyp...